Minova Life Science

Minova life sciences - Pharmaceutical company

Lostar-H Tablets

COMPOSITION –

Losartan Potassium IP 50mg+ Hydrochlorothiazide  IP 12.5mg

Lostar-H Tablets

 

  • Selective angiotensin receptor antagonist that exhibits antihypertensive effect which persists throughout 24 hours
  • Highly effective in the management of patients with hypertension? -Decreases cardiac and skeletal muscle fibrosis and improves cardiac systolic function”
  • Good efficacy and favorable tolerability profile, thereby highly effective in the management of patients with hypertension 2
  • Along with diuretic co-active hydrochlorothiazide (HCTZ), Losartan potassium a potent angiotensin II receptor antagonist shows higher efficacy in treating hypertension than either drug given separately

Explore other products

Scroll to Top